Vascular calcification is an advanced feature of atherosclerosis for which no effective therapy is available. To investigate the modulation or reversal of calcification, we identified calcifying progenitor cells and investigated their calcifying/decalcifying potentials. Cells from the aortas of mice were sorted into four groups using Sca-1 and PDGFRa markers. 
Abstract
Vascular calcification is an advanced feature of atherosclerosis for which no effective therapy is available. To investigate the modulation or reversal of calcification, we identified calcifying progenitor cells and investigated their calcifying/decalcifying potentials. Cells from the aortas of mice were sorted into four groups using Sca-1 and PDGFRa markers. 
/PDGFRa
2 cells in which PPARc was activated displayed markedly decreased plaque severity. Immunofluorescent staining indicated that Sca-1 + /PDGFRa 2 cells mainly expressed osteocalcin; however, activation of PPARc triggered receptor activator for nuclear factor-kB (RANK) expression, indicating their bidirectional fate in vivo. These findings suggest that a subtype of BM-derived and vessel-resident progenitor cells offer a therapeutic target for the prevention of vascular calcification and that PPARc activation may be an option to reverse calcification.
Introduction
Vascular calcification (VC) is a feature of progressive and advanced atherosclerosis that is regarded as a prognostic marker of adverse cardiovascular events [1, 2] . No therapies are available to ameliorate VC [3] . The pathophysiology of VC involves a strict and active regulatory process that resembles bone formation [4] and functions to maintain a balance between osteoblastic and osteoclastic cells [5] . The origin of osteoblastic cells in the vasculature remains an issue of active debate [6] . Resident vascular smooth muscle cells (VSMCs) and calcifying vascular cells have been examined to elucidate the cellular origins of VC.
Pericytes, mesenchymal stem cells (MSCs), myofibroblasts, and circulating osteoprogenitor cells have been isolated from the vasculature and shown to have osteoblastic potential [7] [8] [9] [10] . However, few studies have addressed the origins, features, and roles of osteoclastic and decalcifying cells in the vasculature or the balance between osteoblastic and osteoclastic cells during VC.
In this study, we aimed to identify vascular calcifying progenitor cells and to modulate or reverse VC. We first isolated vesselresident calcifying progenitor cells using stem cell antigen-1 (Sca-1) and platelet-derived growth factor receptor alpha (PDGFRa) antibodies in the vasculature. We then identified a population of nonhematopoietic mesenchymal Sca- 
Results

Osteoblastic and Osteoclastic Differentiation Potentials of Progenitor Cells in the Vasculature
To identify putative calcifying progenitor cells, we stained tissue sections with stem/progenitor markers [11] . We detected markerpositive cells, particularly Sca-1 + cells, in the artery ( Figure S1 ). Sca-1 is a marker of hematopoietic stem cells [12] and MSCs [13] in mice. To distinguish among progenitor cells in the vasculature, we also stained for PDGFRa [14] . Both Sca-1 + and PDGFRa + cells were detected in the artery ( Figure 1A ). Our double-immunostaining enabled us to categorize cells into the following four groups: Sca-1
2 /PDGFRa + , and Sca-1 2 /PDGFR 2 . We subsequently isolated and propagated aortic cells ( Figure S2 ) and performed fluorescence-activated cell sorting (FACS). No difference in sorting was detected between cells sorted immediately ( Figure S3 ) or after 2 wk of cell expansion. We confirmed the purities of the sorted cell populations by immunostaining ( Figure S2C ).
We next assessed the osteoblastic differentiation potentials of the four cell groups over time ( Figure 1B ). Under three osteoblastic differentiation conditions [15] , Sca-1 + cells (Sca-1
showed significantly higher numbers and activities of alkaline phosphatase (ALP)-positive cells than Sca-1
We also confirmed the level of mRNA expression of several osteoblast-related genes in the four groups of cells ( Figure 1C and Figure S4A ,B). Our results indicate that Sca-1 + cells are superior to Sca-1 2 cells in terms of osteoblastic differentiation potentials and osteoblastic fate adaptation capacities. We also determined the osteoclastic potentials of the four cell groups. The cells were cultured in osteoclast differentiation media ( Figure 1D ). Osteoclastic differentiation potentials were then assessed by tartrate-resistant acidic phosphatase (TRAP) staining [16, 17] . The Sca-1 + /PDGFRa 2 cell population was comprised of significantly more TRAP-positive cells than the other three cell groups ( Figure 1E,F) . Under moderate osteoblastic differentiation conditions, Sca-1 + /PDGFRa 2 cells highly expressed the osteoclast-related gene, receptor activator for nuclear factor-kB (RANK), and the osteoblast-related genes, osteoprotegerin (OPG), and RANK ligand (RANKL). However, in serum containing tumor necrosis factor-a (TNF-a), RANK expression was suppressed ( Figure 1C) . We detected the expression of other osteoclast-related genes in Sca-1 + /PDGFRa 2 cells, but not in Sca-1 + /PDGFRa + cells ( Figure 1G and Figure S4C ). To examine whether differentiated Sca-1 + /PDGFRa 2 cells function as osteoclast-like cells, we measured calcium resorption ability. Cells were cultured on a calcium phosphate-coated disc treated with RANKL and macrophage-colony stimulating factor (M-CSF). Observation of the discs by scanning electronic microscopy (SEM) indicated that Sca-1
+
/PDGFRa
2 cells generated wider areas of calcium resorption and greater pore sizes than Sca-1 Figure 1H ). We assayed for the formation of dual actin ring sealing zones [18] . Under osteoclastic differentiation conditions, Sca-1 + /PDGFRa 2 cells cultured on dentine slices formed actin ring of the sealing zones characteristic of active osteoclasts ( Figure 1I ). These structures were absent in Sca-1 migrate into artificial bone structures [19, 20] . These researchers as well as we concluded that PDGFRa was a marker but not a functional receptor for osteoblastogenesis ( Figure S6 ).
Single Clonal Expansion of Calcifying Progenitor Cells
To test the capacity of calcifying progenitor cells from single clones, we performed a clonal expansion assay (Figure 2A ). Sca-1 + cells generated compact and abundant colonies and exhibited a greater colony-forming efficiency than Sca-1 2 cells, which barely generated any colonies ( Figure 2B,C) . We also investigated whether calcifying progenitor cells derived from a single colony could differentiate into either osteoblastic or osteoclastic cells ( Figure 2D ). Single colony-derived Sca-1 + cells differentiated into osteoblasts ( Figure 2E ). Sca-1
+
/PDGFRa
2 clonally expanded cells Figure 2F ), suggesting that this cell population was comprised of bidirectional calcifying progenitor cells with both osteoblastic and osteoclastic differentiation potentials.
The Origin of Calcifying Progenitor Cells in the Artery
Osteoblasts and osteoblastic progenitor cells have been wellcharacterized in the bone and BM [21, 22] . To determine whether calcifying progenitor cells originate in BM, we performed a BM transplantation (BMT) experiment using GFP mice as a marker ( Figure 3A) .
Five days after cell infusion, to rule out the possibility that cells migrated from the intravascular space to vessels, we examined the presence of GFP + cells in the arteries and blood using FACS and immunofluorescent staining. A few GFP + cells from the donor were detected in the peripheral blood (1.5%), but these were rarely detected in the artery (0.2%), indicationg that GFP + cells from donor marrow did not exhibit diapedesis directly into the arterial wall. Twelve weeks after transplantiation ( Figure 3B ), GFP + cells from donor BM reconstituted blood cells in C57 background mice comprised up to 90% of peripheral blood cells. At that point, 13% of arterial resident cells were GFP + . Takgen together, these data indicate that the majority of GFP + cells were gradually incorporated into the artery in a considerable amount of time.
We then determined vessel infiltration of BM-derived GFP + Sca-1 + cells by immunostaining in the artery ( Figure 3C ). We also assessed the possibility of the fusion between BM-derived GFP 
BM-Derived Vessel Resident Calcifying Progenitor Cells Are Nonhematopoietic and Mesenchymal
We subsequently characterized BM-derived and vessel-resident calcifying progenitor cells. Aortas were harvested from Apoe 2/2 mice that underwent GFP-BMT. BM-derived GFP + cells were negative for a hematopoietic lineage antibody cocktail (Lin 2 ) containing antibodies targeting CD3, CD11b (monophage/ macrophage marker), CD45R/B220, TER-11, and Ly-6G. We next isolated vessel-resident calcifying progenitor cells and assessed their differentiation potentials as MSCs. Sca-1 + cells were capable of differentiating into osteoblasts, adipocytes, and chondrocytes ( Figure 4B ). We measured the expression levels of the A small fraction of donor GFP+ cells were detected in peripheral blood (1.5%) but were rarely detected in the artery (0.2%). Twelve weeks after transplantation GFP+ cells from donor BM were reconstituted with peripheral blood cells of C57 mice (up to 90%). At that time, 13% of arterial resident cells were GFP+. Thus, the majority of GFP+ cells gradually were incorporated into the artery within a considerable duration. Bars: 50 mm. (C) Aortas were harvested after 6 mo of BMT and were stained with antibodies targeting GFP, Sca-1, or PDGFRa. The three panels on the right depict high-magnification images of the white squares shown on the left. Blue, Sytox Blue nuclear staining; L, lumen; A, adventitia. White dashed lines describe the media. Bars: yellow = 100 mm; white = 20 mm. Figure 4C ).
Ex Vivo Osteoblastic and Osteoclastic Differentiation of BM-Derived Vascular Calcifying Progenitor Cells and the Modulation of Differentiation by a PPARc Agonist
To confirm the ex vivo osteoblastic and osteoclastic differentiation abilities of BM-derived calcifying progenitor cells, we harvested and cultured cells from the aortas of C57 mice that had undergone GFP-BMT ( Figure S7A ). Cultured aortic cells were divided into four groups of GFP + cells with respect to their Figure S7 ).
PPARc activation has been suggested to repress osteoblastogenesis and to activate osteoclastogenesis [16, 23] . These observations led us to hypothesize that PPARc activation in calcifying progenitor cells might reverse the process of VC. We first confirmed endogenous PPARc expression in Sca-1 + /PDGFRa BM-derived vessel-resident GFP + cells then were cultured in FBS and TNF-a to strongly induce osteoblast differentiation and the influence of an added PPARc agonist was assessed ( Figure 5A ). In the absence of PPARc activation, osteoblastic differentiation was markedly induced ( Figure 5B ). Under the same conditions, PPARc activation of Sca-1 + /PDGFRa 2 cells suppressed osteoblastogenesis ( Figure 5B ) and promoted osteoclastic differentiation ( Figure 5C ). PPARc activation suppressed the expression of osteoblast-related genes and enhanced the expression of osteoclastrelated genes, facilitating the emergence of TRAP-positive cells ( Figure 5B,C) as confirmed by real-time PCR (Figure S8B,C) . These results indicated that PPARc activation not only suppressed the osteoblastic differentiation of vascular cells, but also promoted the osteoclastic differentiation of bidirectional calcifying progenitor cells. Hence, the detrimental process of VC may be preventable as well as reversible.
Calcifying Progenitor Cells Regulate in Vivo Ectopic Mineralization
To verify the in vivo calcifying ability of progenitor cells and the efficacy of PPARc activation, we isolated GFP + calcifying progenitor cells from the arteries of C57 mice that underwent GFP-BMT. GFP + progenitor cells were combined with bone matrix, implanted subcutaneously into WT C57 mice, and a PPARc agonist was injected ( Figure 6A ). After 8 wk of PPARc agonist treatment, X-ray and three-dimensional computed tomography (CT) of the implanted mice indicated a higher mineralization density of a bone-like structure in the Sca-1 + cell groups compared with mice administered phosphate-buffered saline (PBS). This mineralization of mass was remarkably inhibited in Sca-1 + cells treated with a PPARc agonist compared with cells without PPARc activation. Specifically, the bone-like structure of Sca-1 + /PDGFRa 2 cells was dramatically reduced by PPARc activation (Figure 6B,C) . The volume and calcium scores of Sca-1 + cells were higher than those of either PBS-treated or Sca-1 2 cells quantified using the Agatston method ( Figure 6D ) [24] . These scores were significantly increased in Sca-1 + /PDGFRa 2 cells treated with a PPARc agonist. However, no difference was detected between mice injected with PBS or PBS and a PPARc agonist ( Figure 6E ). Masson's trichrome (MT) staining indicated that Sca-1 + cell injection enhanced blue staining, indicating bonelike tissues, whereas PPARc treatment decreased blue staining ( Figure 6F ).
Therefore, we sought to determine the effect of PPARc activation in Sca- We assessed the accumulation of aortic calcium in response to diet. Mice fed a high cholesterol/calcium diet showed a significantly higher level of calcium accumulation than mice fed a normal diet ( Figure 7A) Figure S7 ) and high-cholesterol ( Figure S9 ) diets, and no differences were identified.
The calcium accumulation levels of each cell group were measured from harvested arteries. The groups injected with BM-GFP + Sca-1 + cells, especially BM-GFP + Sca-1 + /PDGFRa 2 cells, showed greater calcium accumulation in tissues than animals injected with PBS. This calcium accumulation was significantly avoided by concurrent treatment with a PPARc agonist. However, no difference in calcium accumulation was measured between mice injected with PBS versus PBS and a PPARc agonist. Therefore, the preventative effects of the GFP 
Discussion
VC occurs by an actively regulated process, but the origin of vascular calcifying cells has not been established. In this study, we demonstrated the origin, in vitro and ex vivo characteristics, and differentiation potentials of a population of vascular calcifying progenitor cells. These cells were confirmed to modulate calcification/decalcification through a series of in vivo experiments. A schematic illustration of calcifying/decalcifying progenitor cells and their proposed actions is presented in Figure 8 .
Recent studies have shown that circulating BM-derived cells could infiltrate via the vasa vasorum (micro vessel) [25] . However, it remained unclear how cells could infiltrate the intima. Others have suggested that the vasa vasorum is increased in the adventitia during inflammation. The vasa vasorum may function as a hallway for cell migration into the adventitia toward atherosclerotic plaques [26, 27] . However, circulating BM-derived cells could directly infiltrate the atherosclerotic plaques. Shimizu et al. demonstrated that cells infiltrating the intima originated as circulating BM-derived cells [28, 29] . Cho et al. reported that cells infiltrating the adventitia did not migrate into the intima and only circulating cells infiltrated the plaque lesion [30] . Our results suggest that under homeostatic noncalcified conditions, circulating BM-derived calcifying cells (Sca-1 + cells) infiltrated the adventitia through the vasa vasorum. However, under pathologic atherosclerotic calcification or therapeutic intravascular cell delivery, these cells might infiltrate into the intima directly from the blood.
Osteoblasts originate from MSCs [6] , whereas osteoclasts are cell-cell fused multinucleated cells derived from granulocyte/ macrophage hematopoietic progenitor cells in the bone [31] . Recently, Eghbali-Fatourechi et al. reported that circulating osteoblastic cells are elevated in adolescents and in patients with fractures, reflecting increased bone formation [32] . However, the roles of circulating osteoblastic cells during VC have not been elucidated. Osteoclast-like cells in the vasculature may originate from circulating hematopoietic cells that were recruited to blood vessels [33] , but this possibility has not been confirmed. Here [35] .
We examined the in vivo modulation of calcifying progenitor cell differentiation by PPARc activation using an ectopic model and an atherosclerotic calcification model. When tissue was double-stained with osteoblast (osteocalcin) and osteoclast (cathepsin K or RANK) markers, Sca-1 + /PDGFRa 2 cells mainly differentiated into osteocalcin-positive cells. However, when cells were cultured with a PPARc agonist, their differentiation shifted from osteoblastic to osteoclastic or double-positive cells in tissue [16, 36] . These results suggest that PPARc activation shifts Sca-1 + /PDGFRa 2 cells from osteoblastic to osteoclastic differentiation in vivo [37, 38] . The concentration of the PPARc agonist, rosiglitazone (5 mg/kg/d), used in the mice study was higher than the human AUC (area under curve) of the FDA-recommended clinical daily dose. Thus, additional study is warranted to find an efficacious novel PPARc agonist. We also investigated the mechanism by which PPARc facilitates osteoblastic differentiation. PPARc activation suppresses osteoblastogenesis by favoring adipogenesis and improving osteoclastogenesis [23, 39] . Wei et al. reported that the transcriptional co-activators of PPARc, PGC1b and ERRa, enable cell differentiation into osteoclasts and adipocytes [40] . These researchers (H) Osteoblastic, osteoclastic, and bidirectional cell counts in the artery. GFP 
Materials and Methods
Animals
Wild-type C57BL/6J mice (KBT Oriental Co Ltd., Charles River Grade, Tosu, Saga, Japan) and ubiquitous enhanced GFP-expressing transgenic mice with a C57 background (The Jackson Laboratory, Bar Harbor, Maine, USA) were used in this study. Apoe 2/2 (B6.129P2-Apoetm1Unc/J; The Jackson Laboratory) mice were used as a model of atherosclerotic calcification. All mice used in this study were males [45] . All procedures were performed in accordance with the Institutional Animal Care and Use Committee of Seoul National University Hospital.
Cell Isolation and Culture
Primary cells cultured from aorta, including the media and adventitia, were prepared by enzyme digestion using collagenase type II (GIBCO) as previously described [46] . Cells were cultured in Mesencult media (Stem Cell Technologies). To examine calcifying progenitor cells, cells were cultured for 2 wk and harvested. They then were stained with the surface markers, Sca-1 (BD Pharmingen) and PDGFRa (Cell Signaling). Sorting was performed using a FACSAria (Becton Dickinson). Sorted cells were divided into the following four groups: Sca-1
, and Sca-1 2 /PDGFRa 2 . To confirm the characteristics of calcifying progenitor cells, cells were stained with using a hematopoietic lineage antibody cocktail (Lin 2 ) containing antibodies targeting CD3, CD11b (monophage/ macrophage marker), CD45R/B220, TER-11, and Ly-6G (BD Pharmingen) or with antibodies targeting CD29 or CD106 (R&D Systems).
Osteoblastic Differentiation
Sorted cells were cultured for 14 d under three osteoblastic differentiation culture conditions in MEM alpha media (GIBCO): 10% charcoal-stripped FBS only, 10% charcoal-stripped FBS with 10 ng/ml TNF-a [15] , and 10% charcoal-stripped FBS containing 6 mM CaCl 2 , 10 mM sodium pyruvate, and 10 mM b-glycerophosphate [47] . Cells were harvested on days 1, 3, 7, and 14 for reverse transcriptase (RT)-PCR or real-time PCR, ALP staining, and ALP activity. To measure ALP activities, cells were grown under osteoblastic differentiation conditions. Harvested cells were washed twice with PBS, lysed in 0.05% Triton-X100 in PBS, and subjected to three freeze/thaw cycles. Cell lysate supernatants were transferred to 96-well plates and were incubated with 50 ml alkaline buffer (Sigma) for 10 min and 50 ml phosphatase substrate capsules (Sigma) until yellow color was observed. P-nitrophenol standard solution (Sigma) was used to generate a standard curve. Absorbance at 405 nm was measured using a plate reader (BioRad). ALP activities were normalized to the protein concentrations of the samples. ALP staining was performed using the BCIP/NBT substrate system (Dako). To evaluate gene expression under osteoblastic differentiation conditions, RT-PCR was performed as previously described [48] . Complementary DNA was PCRamplified using the osteoblastic differentiation markers CBFA-1, OPG, and RANKL (Tables S1 and S2) [49] .
Osteoclastic Differentiation
Sorted cells were cultured in MEM alpha medium with 10% charcoal-stripped FBS (GIBCO), 10 ng/ml M-CSF (R&D Systems), and 100 ng/ml RANKL (R&D Systems) for 7 d [17] . Cells were harvested weekly for RT-PCR. After 7 d of osteoclast differentiation induction, TRAP staining (Sigma) was performed as a measure of osteoclastic activities. TRAP-positive multinucleated cells (.3 nuclei) were counted. RT-PCR or real-time PCR was performed to amplify the following osteoclastic differentiation markers: nuclear factor of activated T-cells-1 (NFATc1), phospholipase C, gamma-1 (PLCc1), TNF receptor-associated factor-6 (TRAF6), RANK, RANKL, c-Fos [50] , and GAPDH (Table S1 and S2). Sca-1 + /PDGFRa + and Sca-1 + /PDGFRa 2 cells were seeded onto calcium phosphate-coated discs (BD bioscience) in 12-well culture plates and were cultured in osteoclastic differentiation media. After 21 d, cells were removed from the discs using a bleach solution. The discs were washed three times with distilled water, air dried, and examined by SEM [51] . Alternatively, after 21 d, cells were stained with FITC-conjugated phalloidin (Sigma) and observed by confocal microscopy [52] .
Clonal Expansion and Osteogenic, Chondrogenic, and Adipogenic Differentiation
To detect MSC-like properties of vessel-resident calcifying progenitor cells, the cells were induced to differentiate into osteoblasts, adipocytes, or chondrocytes by varying the culture conditions. The osteoblast differentiation media consisted of 10% charcoal-stripped FBS with 6 mM CaCl 2 , 10 mM sodium pyruvate, and 10 mM b-glycerophosphate [47] . [53] , collagen 1a1, 2a1, aggrecan [54] , and GAPDH (Table S3) .
Measurement of Aortic Tissue Calcium
To measure calcium levels in aortas of mice fed a normal diet, a high cholesterol diet, or a high cholesterol/calcium diet (7% fat, 3% cholesterol, 200,000 IE/kg vitamin D, 3,000 mg/kg calcium, 1.700 mg/kg phosphate). Isolated aorta tissues were dried at 70uC overnight and weighed. Dried tissues were dissolved in 2 M HCl at 70uC for 24 h. Pellets were obtained and HCl was removed using a vacuum dryer. Dried pellets then were added to 1 ml distilled water. Calcium and phosphorous levels were measured relative to total protein using an autoanalyzer (Hitachi 7070, Tokyo, Japan).
In Vivo Ectopic Calcification Assay
Calcifying progenitor cells were collected and sorted from the arteries of GFP-BMT mice that had been fed a high cholesterol diet. Cells were mixed with triosite (Zimmer) and were incubated for 1 h. Transplanted cells then were mixed with fibrinogen and thrombin before being implanted into a subcutaneous pocket of an 8-wk-old C57 mouse. Eight weeks later, ectopic mineralization was assessed by X-ray (TU-3000DR, Hitachi) and CT (Somatom Definition; Siemens Medical Solutions, Forchheim, Germany) and was quantified using the Agatston score [32, 55, 56] . Ectopically mineralized tissues were harvested and embedded in paraffin. /100 ml) were injected into the tail veins of Apoe 2/2 mice 4 times at 2-wk intervals. Apoe 2/2 mice were fed a high cholesterol diet for 10 wk prior to cell injection. Mice continued the high cholesterol/calcium diet for another 8 wk following injection. To test the effect of PPARc activation in vivo, the PPARc agonist (rosiglitazone, 10 mg/kg) was injected intraperitoneally into mice 3 times per week for 8 wk. Arteries were harvested, and calcium and phosphorus levels were measured. Atherosclerotic plaque formation and calcium deposits were evaluated by MT and von Kossa staining.
Atherosclerotic Calcification in Apoe
Statistical Analysis
All data were presented as means 6 SEM. Intergroup comparisons were performed using the Student's t test or oneway analysis of variance (ANOVA). Data obtained at different time points were analyzed by repeated measures ANOVA. SPSS v16.0 was used for all statistical analyses, and P,0.05 was considered statistically significant. 
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